[ESPR] YoY Quarter Result on 30-Sep-2015 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
05-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- -3.28%
YoY- -30.54%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -49,911 -45,219 -17,402 -12,801 -9,806 -5,238 -3,351 56.82%
Tax 0 606 488 378 164 168 362 -
NP -49,911 -45,219 -17,402 -12,801 -9,806 -5,238 -3,351 56.82%
Tax Rate - - - - - - - -
Total Cost 49,911 45,219 17,402 12,801 9,806 5,238 3,351 56.82%
Ratio Analysis
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
EPS -1.86 -1.86 -0.77 -0.57 -0.64 -0.34 -0.35 32.08%
EPS Diluted -1.86 -1.86 -0.77 -0.57 -0.64 -0.34 -0.35 32.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.